Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results – (Eye 29, 1152 (September 2015))

10 September 2015

This news item is available to RCOphth members only, please log in below to access.